Monte Rosa Therapeutics
GLUE
GLUE
81 hedge funds and large institutions have $264M invested in Monte Rosa Therapeutics in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 41 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 74 → 81 (+7)
6.12% more ownership
Funds ownership: 74.96% → 81.07% (+6.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
81
Holding in Top 10
1
Calls
$895K
Puts
$165K
Top Buyers
| 1 | +$6.65M | |
| 2 | +$3.3M | |
| 3 | +$2.87M | |
| 4 |
PL
Parkwood LLC
Cleveland,
Ohio
|
+$2.26M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.65M |
Top Sellers
| 1 | -$1.36M | |
| 2 | -$928K | |
| 3 | -$270K | |
| 4 |
SP
Sarasin & Partners
London,
United Kingdom
|
-$243K |
| 5 |
Renaissance Technologies
New York
|
-$191K |